Pfizer, Merck KGaA lung cancer drug fails; J&J gets first-of-its-kind prostate cancer approval; DBV shares jump as peanut allergy patch heads to filing; Bioverativ taps new manufacturer as it steps out of Biogen's shadow
The BioPharma Dive Brand Studio teamed up with Catalent to survey hundreds of executives and key stakeholders in the clinical trial space. For access to the survey results, download the free report »
Our mission is to provide busy execs like you with an overview of the BioPharma industry in 60 seconds. BioPharma Dive is a product of Industry Dive. View other Industry Dive publications.
This email is optimized for display on mobile phones. BioPharma Dive is a product of Industry Dive, Inc.. 1575 Eye St NW, 4th Floor, Washington, DC 20005. We value your privacy. We won't share your email address with anyone else without your permission. This message was sent to [email protected]. You can unsubscribe or change which newsletters you receive anytime. See our full privacy policy.